Do You Have Atrial Fibrillation?

You may be eligible to participate in a clinical research study evaluating the efficacy and safety of an investigational medication compared to an approved medication.

The study is open to men and women who:

• are 18 years old or older
• have ECG or Holter documentation of a permanent or persistent atrial fibrillation or atrial flutter
• have one or more risk factor(s) for stroke

Participants will receive study related visits, procedures and study medication at no cost. Time and travel expenses will be compensated.

Principal Investigator:
Michael Wukelic, M.D

Contact: DeAnn at (509) 755-6546 (Refer to CTNA study)